Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription Articles published in J Clin Psychiatry Retrieve available abstracts of 38 articles: HTML format

Single Articles

August 2025
1. ANDRADE C
   The Superiority of Clozapine Over Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: Room for Doubt.
   J Clin Psychiatry. 2025;86:25f16038.
   PubMed     Abstract available
   
   
   
2. CORRELL CU, Achtyes ED, Sajatovic M, Saklad SR, et al
   Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report.
   J Clin Psychiatry. 2025;86:plunlai2424ah2.
   PubMed     Abstract available
   
   
   
3. CHOI BM, Singh T, Nili M, Lam C, et al
   Understanding the Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US: Medical Expenditure Panel Survey.
   J Clin Psychiatry. 2025;86:25m15794.
   PubMed     Abstract available
   
   
   July 2025
4. ZHANG T, Xu L, Wei Y, Tang X, et al
   Efficiency and Extent of Niacin-Induced Skin Flushing Patterns in Early Stages of Psychosis.
   J Clin Psychiatry. 2025;86:24m15559.
   PubMed     Abstract available
   
   
   
5. BALLESTEROS A, Flores-Lopez M, Sanchez-Torres AM, Gil-Berrozpe GJ, et al
   Exploring Vascular Endothelial Growth Factor and Other Blood-Brain Barrier Biomarkers in Cognition of First-Episode Psychosis: An Observational Study.
   J Clin Psychiatry. 2025;86:24m15486.
   PubMed     Abstract available
   
   
   June 2025
6. ANDRADE C
   Schizophrenia, Antipsychotic Drugs, and Risk of Breast Cancer.
   J Clin Psychiatry. 2025;86:25f15960.
   PubMed     Abstract available
   
   
   
7. GOLDBERG JF, Achtyes ED, Correll CU, Sajatovic M, et al
   Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report.
   J Clin Psychiatry. 2025;86:plunlai2424ah1.
   PubMed     Abstract available
   
   
   
8. RICCIARDI FL, Melnitsky JL, Peleg SB, Govil P, et al
   Worth the Weight? The Challenges of Administering the Glucagon-Like Peptide 1 Receptor Agonist Semaglutide With Long-Term Olanzapine Use in a Patient With Schizophrenia.
   J Clin Psychiatry. 2025;86:25cr15857.
   PubMed    
   
   
   March 2025
9. TSAI SJ, Cheng CM, Chang WH, Bai YM, et al
   Effects of Parental Severe Mental Disorders on All-Cause and Suicide Mortalities in Adolescents and Young Adults With Major Depressive Disorder.
   J Clin Psychiatry. 2025;86:24m15476.
   PubMed     Abstract available
   
   
   
10. YEUNG PP, Breier A, Zhu H, Kaul I, et al
    Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials.
    J Clin Psychiatry. 2025;86:24m15668.
    PubMed     Abstract available
    
    
    February 2025
11. KAUL I, Claxton A, Sawchak S, Sauder C, et al
    Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the 5-Week, Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials.
    J Clin Psychiatry. 2025;86:24m15497.
    PubMed     Abstract available
    
    
    
12. CITROME L
    Understanding the Tolerability Profile of Xanomeline-Trospium Combination for the Treatment of Schizophrenia.
    J Clin Psychiatry. 2025;86:25com15775.
    PubMed    
    
    
    January 2025
13. RAMIREZ J, Correll CU
    Relationship Between Trauma, PTSD, and Schizophrenia: Relevance for Outcomes, Screening, and Interventions.
    J Clin Psychiatry. 2025;86:24ac15773.
    PubMed    
    
    
    
14. DIALLO-MONTFORD K, Schwind JS, Smallwood SW, Qotineh A, et al
    Psychological Challenges of Adults With Severe Mental Illness During the COVID-19 Pandemic.
    J Clin Psychiatry. 2025;86:24m15448.
    PubMed     Abstract available
    
    
    
15. HUANG J, Chen A, Jin H, Liu F, et al
    Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia: A Randomized Controlled Trial.
    J Clin Psychiatry. 2025;86:24m15272.
    PubMed     Abstract available
    
    
    
16. CORRELL CU, Doane MJ, McDonnell D, Akerman S, et al
    Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studies.
    J Clin Psychiatry. 2025;86:24m15526.
    PubMed     Abstract available
    
    
    December 2024
17. BALLON JS, Kahn RS, Arevalo C, Dunbar M, et al
    Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study.
    J Clin Psychiatry. 2024;86:24m15511.
    PubMed     Abstract available
    
    
    November 2024
18. JAIN R, Chepke C, Davis LL, McIntyre RS, et al
    Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder.
    J Clin Psychiatry. 2024;85:plunaro2417ah.
    PubMed     Abstract available
    
    
    September 2024
19. DE WINTER L, Jelsma A, Vermeulen JM, van Tricht M, et al
    Long-Term Changes in Cognition Among Patients With Schizophrenia Spectrum Disorders and Different Durations of Illness: A Meta-Analysis.
    J Clin Psychiatry. 2024;85:23r15134.
    PubMed     Abstract available
    
    
    August 2024
20. CORRELL CU, Xiang P, Sarikonda K, Bhagvandas N, et al
    The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia: A Targeted Literature Review With a Focus on Outcomes Relevant to Health Care Decision-Makers in the United States.
    J Clin Psychiatry. 2024;85:24r15316.
    PubMed     Abstract available
    
    
    
21. KINON BJ, Leucht S, Tamminga C, Breier A, et al
    Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia.
    J Clin Psychiatry. 2024;85:23nr15240.
    PubMed     Abstract available
    
    
    
22. SOMMI RW, Saklad SR, Weiden PJ, Still D, et al
    Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
    J Clin Psychiatry. 2024;85:23m15132.
    PubMed     Abstract available
    
    
    June 2024
23. VACCARINO SR, Vaccarino AL
    Cognitive Effects of Electroconvulsive Therapy in Schizophrenia: A Systematic Review.
    J Clin Psychiatry. 2024;85:23r15045.
    PubMed     Abstract available
    
    
    May 2024
24. KOBYLSKI LA, Le HN, Freeman MP, Cohen LS, et al
    Enhancing Postpartum Psychosis Care With Qualitative Research: Current Findings and Future Directions.
    J Clin Psychiatry. 2024;85:24com15305.
    PubMed    
    
    
    
25. NASRALLAH HA
    Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma.
    J Clin Psychiatry. 2024;85:24com15310.
    PubMed    
    
    
    
26. CUNAT O, Arranz B, Vila-Badia R, Serra-Arumi C, et al
    Relationship Between Exposure to Emotional Neglect and the Inflammatory Biomarkers Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, and Platelet-to-Lymphocyte Ratios in Patients With First-Episode Psychosis.
    J Clin Psychiatry. 2024;85:23m15141.
    PubMed     Abstract available
    
    
    
27. BRAINERD DR, Alexander B, Tague MJ, Lund BC, et al
    Association Between Clozapine Exposure and Risk of Hematologic Malignancies in Veterans With Schizophrenia.
    J Clin Psychiatry. 2024;85:23m15149.
    PubMed     Abstract available
    
    
    
28. ANDRADE C
    Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
    J Clin Psychiatry. 2024;85:24f15363.
    PubMed     Abstract available
    
    
    
29. TIEN Y, Wang XY, Huang SC, Huang HP, et al
    Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
    J Clin Psychiatry. 2024;85:23m15071.
    PubMed     Abstract available
    
    
    April 2024
30. SIMON GE, Rossom RC, Iturralde E, Ahmedani BK, et al
    Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine.
    J Clin Psychiatry. 2024;85:23m14833.
    PubMed     Abstract available
    
    
    February 2024
31. CITROME L, Yagoda S, Bidollari I, Wang M, et al
    Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophre
    J Clin Psychiatry. 2024;85:23m15095.
    PubMed     Abstract available
    
    
    January 2024
32. MIURA I, Sano F, Sakaguchi R, Okamoto K, et al
    Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study.
    J Clin Psychiatry. 2024;85:23m14881.
    PubMed     Abstract available
    
    
    
33. ITURRALDE E, Fazzolari L, Slama NE, Alexeeff SE, et al
    Telehealth Collaborative Care Led by Clinical Pharmacists for People With Psychosis or Bipolar Disorder: A Propensity Weighted Comparison With Usual Psychiatric Care.
    J Clin Psychiatry. 2024;85:23m14917.
    PubMed     Abstract available
    
    
    November 2023
34. LONDON SM, Cawkwell PB, Shinn AK
    Medication Adherence in a Transdiagnostic First-Episode Psychosis Sample.
    J Clin Psychiatry. 2023;84:23m14947.
    PubMed     Abstract available
    
    
    October 2023
35. VERGARA L, de la Serna E, Sugranyes G, Puig O, et al
    Obsessive-Compulsive Spectrum Symptoms Are Associated With Functional Impairment in Children and Adolescents With Psychosis Risk Syndrome: The CAPRIS Study.
    J Clin Psychiatry. 2023;84:22m14698.
    PubMed     Abstract available
    
    
    September 2023
36. LOPENA OJ, Alphs LD, Sajatovic M, Turkoz I, et al
    Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.
    J Clin Psychiatry. 2023;84:23m14788.
    PubMed     Abstract available
    
    
    
37. CHENG CM, Chang WH, Tsai SJ, Li CT, et al
    Risk of All-Cause and Suicide Death in Patients With Schizophrenia: An Entire-Population Longitudinal Study in Taiwan.
    J Clin Psychiatry. 2023;84:22m14747.
    PubMed     Abstract available
    
    
    
38. CITROME L, Such P, Yildirim M, Madera-McDonough J, et al
    Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
    J Clin Psychiatry. 2023;84:23m14873.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.